vs
MIND TECHNOLOGY, INC（MIND）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
MIND TECHNOLOGY, INC的季度营收约是Protalix BioTherapeutics, Inc.的1.1倍（$9.7M vs $9.1M），MIND TECHNOLOGY, INC净利率更高（0.6% vs -60.3%，领先61.0%），MIND TECHNOLOGY, INC同比增速更快（-20.0% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $801.0K），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -14.9%）
MIND TECHNOLOGY, INC成立于1987年，总部位于得克萨斯州亨茨维尔，主要向开展陆地、沼泽及深浅水区域勘探的地震数据采集承包商销售地球物理勘探及其他相关设备。公司主要运营两大业务板块，分别为设备租赁和设备制造，2011年10月还在匈牙利布达佩斯新设了一处物流与维修中心。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
MIND vs PLX — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.7M | $9.1M |
| 净利润 | $62.0K | $-5.5M |
| 毛利率 | 46.6% | 49.4% |
| 营业利润率 | 8.0% | -51.1% |
| 净利率 | 0.6% | -60.3% |
| 营收同比 | -20.0% | -49.9% |
| 净利润同比 | -95.2% | -184.8% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $9.7M | $9.1M | ||
| Q3 25 | $13.6M | $17.9M | ||
| Q2 25 | $7.9M | $15.7M | ||
| Q1 25 | $15.0M | $10.1M | ||
| Q4 24 | $12.1M | $18.2M | ||
| Q3 24 | $10.0M | $18.0M | ||
| Q2 24 | $9.7M | $13.5M | ||
| Q1 24 | $13.4M | — |
| Q4 25 | $62.0K | $-5.5M | ||
| Q3 25 | $1.9M | $2.4M | ||
| Q2 25 | $-970.0K | $164.0K | ||
| Q1 25 | $2.0M | $-3.6M | ||
| Q4 24 | $1.3M | $6.5M | ||
| Q3 24 | $798.0K | $3.2M | ||
| Q2 24 | $954.0K | $-2.2M | ||
| Q1 24 | $1.4M | — |
| Q4 25 | 46.6% | 49.4% | ||
| Q3 25 | 50.4% | 53.4% | ||
| Q2 25 | 42.2% | 62.5% | ||
| Q1 25 | 43.5% | 19.1% | ||
| Q4 24 | 44.8% | 78.7% | ||
| Q3 24 | 47.6% | 53.4% | ||
| Q2 24 | 43.6% | 29.8% | ||
| Q1 24 | 46.7% | — |
| Q4 25 | 8.0% | -51.1% | ||
| Q3 25 | 19.6% | 11.9% | ||
| Q2 25 | -8.3% | 7.5% | ||
| Q1 25 | 18.5% | -41.0% | ||
| Q4 24 | 15.5% | 39.6% | ||
| Q3 24 | 14.2% | 22.2% | ||
| Q2 24 | 7.5% | -18.0% | ||
| Q1 24 | 17.3% | — |
| Q4 25 | 0.6% | -60.3% | ||
| Q3 25 | 14.2% | 13.2% | ||
| Q2 25 | -12.3% | 1.0% | ||
| Q1 25 | 13.5% | -35.8% | ||
| Q4 24 | 10.7% | 35.6% | ||
| Q3 24 | 8.0% | 18.0% | ||
| Q2 24 | 9.9% | -16.4% | ||
| Q1 24 | 10.8% | — |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.4M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $39.9M | $48.2M |
| 总资产 | $47.3M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $19.4M | $14.7M | ||
| Q3 25 | $7.8M | $13.6M | ||
| Q2 25 | $9.2M | $17.9M | ||
| Q1 25 | $5.3M | $19.5M | ||
| Q4 24 | $3.5M | $19.8M | ||
| Q3 24 | $1.9M | $27.4M | ||
| Q2 24 | $924.0K | $23.4M | ||
| Q1 24 | $5.3M | — |
| Q4 25 | $39.9M | $48.2M | ||
| Q3 25 | $28.8M | $52.9M | ||
| Q2 25 | $26.6M | $49.9M | ||
| Q1 25 | $27.3M | $45.2M | ||
| Q4 24 | $25.2M | $43.2M | ||
| Q3 24 | $24.5M | $32.4M | ||
| Q2 24 | $23.6M | $28.6M | ||
| Q1 24 | $22.6M | — |
| Q4 25 | $47.3M | $82.3M | ||
| Q3 25 | $35.8M | $82.3M | ||
| Q2 25 | $36.2M | $78.5M | ||
| Q1 25 | $36.7M | $73.9M | ||
| Q4 24 | $36.1M | $73.4M | ||
| Q3 24 | $37.8M | $61.6M | ||
| Q2 24 | $34.9M | $91.5M | ||
| Q1 24 | $33.5M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $894.0K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $801.0K | $1.6M |
| 自由现金流率自由现金流/营收 | 8.3% | 17.8% |
| 资本支出强度资本支出/营收 | 1.0% | 4.4% |
| 现金转化率经营现金流/净利润 | 14.42× | — |
| 过去12个月自由现金流最近4个季度 | $5.1M | $-13.6M |
8季度趋势，按日历期对齐
| Q4 25 | $894.0K | $2.0M | ||
| Q3 25 | $-1.2M | $-3.7M | ||
| Q2 25 | $4.1M | $-5.2M | ||
| Q1 25 | $2.1M | $-5.1M | ||
| Q4 24 | $2.3M | $4.0M | ||
| Q3 24 | $1.1M | $4.1M | ||
| Q2 24 | $-4.8M | $-3.6M | ||
| Q1 24 | $657.0K | — |
| Q4 25 | $801.0K | $1.6M | ||
| Q3 25 | $-1.3M | $-4.2M | ||
| Q2 25 | $3.8M | $-5.7M | ||
| Q1 25 | $1.8M | $-5.4M | ||
| Q4 24 | $2.2M | $3.6M | ||
| Q3 24 | $978.0K | $4.0M | ||
| Q2 24 | $-4.8M | $-3.8M | ||
| Q1 24 | $566.0K | — |
| Q4 25 | 8.3% | 17.8% | ||
| Q3 25 | -9.9% | -23.7% | ||
| Q2 25 | 48.5% | -36.2% | ||
| Q1 25 | 12.2% | -53.0% | ||
| Q4 24 | 18.3% | 19.6% | ||
| Q3 24 | 9.7% | 22.4% | ||
| Q2 24 | -49.8% | -28.1% | ||
| Q1 24 | 4.2% | — |
| Q4 25 | 1.0% | 4.4% | ||
| Q3 25 | 1.3% | 2.8% | ||
| Q2 25 | 3.0% | 2.8% | ||
| Q1 25 | 1.5% | 3.0% | ||
| Q4 24 | 0.6% | 2.3% | ||
| Q3 24 | 0.8% | 0.5% | ||
| Q2 24 | 0.7% | 1.3% | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 14.42× | — | ||
| Q3 25 | -0.60× | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 1.77× | 0.61× | ||
| Q3 24 | 1.33× | 1.27× | ||
| Q2 24 | -4.98× | — | ||
| Q1 24 | 0.46× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIND
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
